Medical News

RSS

Bayer announces Health Canada approval of Nexavar for differentiated thyroid cancer treatment

Bayer Inc. is pleased to announce the Health Canada approval of Nexavar for the treatment of patients with locally advanced or metastatic, progressive, differentiated thyroid carcinoma (DTC), refractory to radioactive iodine (RAI).

7 Jul 2014

AutoGenomics, Genomas sign agreement to develop DNA-guided diagnostic systems

AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity and diabetes.

7 Jul 2014

First Edition: July 7, 2014

Today's headlines include a range of stories related to the implementation of the health law, and the politics surrounding it.

7 Jul 2014

Researchers develop new "nanojuice" to help doctors better identify human gut

Located deep in the human gut, the small intestine is not easy to examine. X-rays, MRIs and ultrasound images provide snapshots but each suffers limitations. Help is on the way.

7 Jul 2014

Investigators report effects of internet based treatment on obsessive symptoms

A group of German investigators reports on the affects of internet based treatment on obsessive symptoms in the current issue of Psychotherapy and Psychosomatics.

7 Jul 2014

Treating ulcerative colitis and Crohn’s disease

Ulcerative colitis and Crohn’s disease are idiopathic (we don’t know the cause) inflammatory diseases (IBD) of the colon and/or small bowel. They are chronic in that we do not have a medical cure and are differentiated from IBS (irritable bowel syndrome) by inflammation that causes ulcerations of the GI tract.

7 Jul 2014

Research on intestinal microbiota overturns vision of human gut ecosystem

An international research team within the MetaHIT consortium coordinated by INRA and involving teams from CEA, CNRS and Université d'Evry, has developed a new method to analyse the global genome, or the metagenome of the intestinal microbiota.

7 Jul 2014

Study analyzes effects of antidepressant drugs on well-being in children and adolescents

In an article published in the current issue of Psychotherapy and Psychosomatics the effects of antidepressant drugs on well-being in children and adolescents are analyze.

7 Jul 2014

NIFTY test becomes first CFDA approved NIPT based on Next Generation Sequencing Technology

BGI Diagnostics' NIFTY™ test becomes First NIPT based on Next Generation Sequencing Technology to be Approved by the China Food and Drug Administration (CFDA).

7 Jul 2014

Grunenthal Group submits Marketing Authorization Application to EMA for ZALVISO

AcelRx Pharmaceuticals, Inc. and Grunenthal Group announced today that Grunenthal has submitted a Marketing Authorization Application (MAA) to the European Medicines Authority for ZALVISO for the management of moderate to severe acute pain in adult patients in a medically supervised environment.

7 Jul 2014

Scientists develop chip for detection of RNA strand of dengue fever virus

Scientists at the Center for Research and Advanced Studies (Cinvestav) in Mexico developed a chip (also known as cDNA microarray) that allows detection of the RNA strand of the dengue fever virus.

7 Jul 2014

Researchers map unknown microorganisms in human intestinal flora

Researchers from DTU Systems Biology have mapped 500 previously unknown microorganisms in human intestinal flora as well as 800 also unknown bacterial viruses (also called bacteriophages) which attack intestinal bacteria.

7 Jul 2014

Study analyzes difference between day hospital and inpatient stay in depression

A study published in the current issue of Psychotherapy and Psychosomatics has analyzed the difference between day hospital and inpatient stay in depression.

7 Jul 2014

New approach may provide missing link between clinical states and biomarkers in psychiatry

In an article published in the current issue of Psychotherapy and Psychosomatics, researchers from the University of Bologna and Bern analyze the state of biological research in mental disorders.

7 Jul 2014

Poor nutrition, health cause disparities in fetal growth and newborn size worldwide

Babies' growth in the womb and their size at birth, especially their length, are strikingly similar the world over - when babies are born to healthy, well-educated and well-nourished mothers.

7 Jul 2014

New study explores relationship between personality and heart attacks

A new study published in the current issue of Psychotherapy and Psychosomatics has addressed the relationship between personality and heart attacks.

7 Jul 2014

Findings shed light on possible role of affective temperaments in cardiovascular morbidity

Temperament has been traditionally associated with high blood pressure. A new study that has appeared in the current issue of Psychotherapy and Psychosomatics has substantiated this issue.

7 Jul 2014

Global toolkit for managing menopause

Created at Monash University, the world's first toolkit is designed for GPs to use with women from the age of 40. Thought to be the first of its kind, researchers say the toolkit has the potential to help manage menopausal conditions for women globally.

7 Jul 2014

Hospira acquires API manufacturing and R&D facilities from Orchid for about $218 million

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and development (R&D) facility from Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $218 million, after settling prior advances of approximately $30 million.

7 Jul 2014

Researchers find novel inhibitor that prevents cholera toxin from binding to carbohydrates

Cholera against cholera: a novel inhibitor prevents the cholera toxin from binding to carbohydrates found on the surface of intestinal cells.

7 Jul 2014

Medical News

Bayer announces Health Canada approval of Nexavar for differentiated thyroid cancer treatment

AutoGenomics, Genomas sign agreement to develop DNA-guided diagnostic systems

First Edition: July 7, 2014

Researchers develop new "nanojuice" to help doctors better identify human gut

Investigators report effects of internet based treatment on obsessive symptoms

Treating ulcerative colitis and Crohn’s disease

Research on intestinal microbiota overturns vision of human gut ecosystem

Study analyzes effects of antidepressant drugs on well-being in children and adolescents

NIFTY test becomes first CFDA approved NIPT based on Next Generation Sequencing Technology

Grunenthal Group submits Marketing Authorization Application to EMA for ZALVISO

Scientists develop chip for detection of RNA strand of dengue fever virus

Researchers map unknown microorganisms in human intestinal flora

Study analyzes difference between day hospital and inpatient stay in depression

New approach may provide missing link between clinical states and biomarkers in psychiatry

Poor nutrition, health cause disparities in fetal growth and newborn size worldwide

New study explores relationship between personality and heart attacks

Findings shed light on possible role of affective temperaments in cardiovascular morbidity

Global toolkit for managing menopause

Hospira acquires API manufacturing and R&D facilities from Orchid for about $218 million

Researchers find novel inhibitor that prevents cholera toxin from binding to carbohydrates

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News